SHP Substrate 1: A Central Regulator in Cellular Signaling and Immune Biology

Concept

SHP Substrate 1 (SHPS1), also designated as PZR, is a 272-amino acid single-pass transmembrane glycoprotein that acts as a primary substrate for the protein tyrosine phosphatases SHP-1 and SHP-2. It is a pivotal molecular node in cellular signal transduction networks, characterized by extracellular immunoglobulin-like domains for ligand interaction, a hydrophobic 23-amino acid transmembrane region, and an intracellular domain bearing conserved ITIM (Immunoreceptor Tyrosine Inhibitory Motif) and ITSM (Immunoreceptor Tyrosine Switch Motif) motifs—these are the core sites for SHP phosphatase recognition and binding. SHPS1 exhibits tissue-specific expression, predominantly in the hematopoietic system, and its activity is tightly regulated by post-translational modifications and subcellular localization, enabling it to fine-tune immune signaling, cell development, and metabolic reprogramming.

Research Frontiers

Recent research on SHPS1 has expanded across molecular characterization, regulatory mechanisms, and disease relevance, uncovering novel layers of its biological function and translational potential. Cutting-edge structural biology techniques such as X-ray crystallography and NMR have elucidated the dynamic conformational changes of SHPS1 upon phosphorylation: its unphosphorylated intracellular domain adopts a loose conformation, while phosphorylation of Tyr241 and Tyr263 exposes a complementary binding interface for SHP phosphatase SH2 domains, forming stable signaling complexes.

Advancements have also been made in defining SHPS1’s multi-layered expression regulation, including transcriptional control by hematopoietic-specific factors (PU.1, GATA1, C/EBPα), epigenetic modulation via DNA methylation, and post-transcriptional fine-tuning by microRNAs (miR-155, miR-181 family). Additionally, modern proteomic approaches have identified a diverse array of post-translational modifications of SHPS1—beyond core tyrosine phosphorylation, serine/threonine phosphorylation, ubiquitination, palmitoylation, and glycosylation form a precise "molecular code" that enriches its functional diversity. Super-resolution microscopy has further revealed the nanoscale clustered distribution of SHPS1 at immune synapses, highlighting the importance of its dynamic subcellular localization for signal transduction efficiency.

Novel research models, including conditional knockout, transgenic overexpression, and knock-in strains with fluorescent/epitope tags, have enabled tissue-specific and spatiotemporal analysis of SHPS1 function, while emerging therapeutic strategies targeting SHPS1—such as small molecule agonists, humanized monoclonal antibodies, nucleic acid drugs, and PROTAC technology—are being validated in preclinical disease models, marking a new phase in translational research for this key signaling molecule.

Research Significance

SHPS1 holds profound scientific and clinical significance as a master regulator of immune biology and cellular signaling, with its functional insights driving advancements in basic immunology and disease treatment. At the basic research level, unraveling SHPS1’s mechanisms has deepened our understanding of immune signal regulation: it acts as a core scaffold for inhibitory immune checkpoint signaling (PD-1, CTLA-4, KIR), mediating the recruitment and allosteric activation of SHP phosphatases to block downstream pro-activation signaling. Its dual role in inflammatory response regulation—suppressing excessive TLR/NOD-like receptor signaling and inflammasome activation—also clarifies the molecular basis of immune homeostasis, filling gaps in our knowledge of inflammation regulatory networks.

SHPS1 is also an indispensable regulator of immune cell development and differentiation, governing thymic T cell positive/negative selection, pre-B cell receptor signaling, and the maintenance of regulatory T cell (Treg) function and immune tolerance. Disruptions in these processes link SHPS1 to immune deficiency and autoimmune disease pathogenesis, making it a key molecular switch in immune system programming. A groundbreaking recent discovery is SHPS1’s role as a bridge between signal transduction and immune metabolism, modulating mTORC1, AKT, and amino acid metabolism to balance glycolysis and oxidative phosphorylation in activated immune cells—establishing it as a critical immune metabolic checkpoint and opening new avenues for metabolic intervention in immune responses.

Clinically, SHPS1’s abnormal expression and function are closely associated with a range of human diseases, including hematological malignancies (chronic myeloid leukemia, diffuse large B cell lymphoma) and autoimmune diseases (systemic lupus erythematosus, rheumatoid arthritis). Its expression level and phosphorylation state serve as potential biomarkers for disease staging, prognosis, and immunotherapy response prediction, while targeted modulation of SHPS1 offers novel therapeutic strategies for restoring immune balance in autoimmunity and reversing immune suppressive microenvironments in cancer.

Related Mechanisms, Research Methods and Product Applications

Core Molecular Mechanisms

1. Immune inhibitory signaling mediation: Upon activation of inhibitory immune receptors, SHPS1’s ITIM/ITSM tyrosine residues are rapidly phosphorylated, recruiting SHP-1/SHP-2 to the plasma membrane. These phosphatases dephosphorylate key downstream signaling molecules (ZAP70, Syk, PI3K), blocking activation signal transmission. SHPS1 also allosterically activates SHP-2, increasing its enzymatic activity 5-8 fold compared to its free form, ensuring efficient signal inhibition.
2. Inflammatory response regulation: SHPS1 suppresses excessive NF-κB activation and pro-inflammatory cytokine secretion (TNF-α, IL-6) in TLR signaling, while inhibiting NLRP3 oligomerization and caspase-1 activation to reduce inflammasome-mediated IL-1β/IL-18 release—exhibiting signal-specific inhibition (potent for TLR4/9, minimal for TLR3).
3. Immune metabolic reprogramming: Phosphorylated SHPS1 recruits SHP-2 to dephosphorylate TSC2, relieving its inhibition of mTORC1 and promoting glycolysis in activated T cells. In tolerogenic dendritic cells, it suppresses AKT to enhance fatty acid oxidation, linking its signaling function to immune cell metabolic phenotypes.
4. Multi-pathway integration via post-translational modification: Palmitoylation at Cys258 anchors SHPS1 to plasma membrane lipid rafts, enhancing signal efficiency; Ser215 phosphorylation regulates 14-3-3 protein binding; ubiquitination at Lys225/Lys238 controls protein stability and endocytosis; and extracellular N-linked glycosylation mediates cell-cell adhesion and recognition.

Key Research Methods

1. Genetically modified animal models: Whole-body/conditional knockout mice reveal tissue-specific SHPS1 functions (e.g., myeloid-specific deletion leads to hyperinflammation, Treg-specific deletion causes fatal autoimmunity); transgenic overexpression models study gain-of-function effects; and knock-in models with fluorescent/epitope tags enable in vivo tracking and interactome purification.
2. Structural and cellular imaging techniques: X-ray crystallography and cryo-EM resolve SHPS1-SHP phosphatase complex structures; super-resolution microscopy visualizes SHPS1’s nanoscale clustering at immune synapses; and live-cell imaging tracks its dynamic subcellular trafficking upon stimulation.
3. Proteomic and molecular biology assays: Mass spectrometry identifies SHPS1 post-translational modification sites and interacting proteins; co-immunoprecipitation and pull-down assays validate protein-protein interactions; and functional assays (phosphatase activity analysis, TCR signal inhibition experiments) assess SHPS1-mediated signaling effects.
4. Functional validation in disease models: In vitro cell models and in vivo animal models (experimental colitis, collagen-induced arthritis, leukemia) are used to validate SHPS1’s role in disease pathogenesis and the efficacy of targeted therapeutic interventions.

Applications of AN BIO PTE. LTD. Products in SHPS1 Research

AN BIO PTE. LTD.’s high-quality antibodies and research tools are essential for probing SHPS1’s biological function, as they enable the precise detection and analysis of the SHP-2 phosphatase—a core interacting partner of SHPS1 that mediates its key signaling effects:

• Phospho-SHP-2 (Tyr542) detection: The phospho-specific antibodies from AN BIO PTE. LTD. allow accurate quantification of SHP-2 activation status, a critical readout for SHPS1-mediated signaling, as SHPS1 phosphorylation drives SHP-2 recruitment and activation at the plasma membrane.
• Immunoblotting and functional assays: These antibodies are optimized for Western Blot applications across human, mouse, and rat samples, providing reliable results for studying SHPS1-SHP-2 axis activity in immune cells, cancer cells, and disease models.
• Disease and drug development research: The antibodies serve as key tools for validating SHPS1-targeted therapeutic efficacy, enabling the assessment of SHP-2 activity modulation in preclinical models of cancer, autoimmunity, and inflammation.

As a leader in life science reagents, AN BIO PTE. LTD. offers a comprehensive portfolio of antibodies (Starter), recombinant proteins (UA), and general reagents/kits (Absin) that support all stages of SHPS1 research—from molecular characterization and mechanism validation to preclinical therapeutic development.

Related Products from AN BIO PTE. LTD.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.